Literature DB >> 3292426

Liver transplantation for metabolic disease of the liver.

C O Esquivel1, I R Marino, V Fioravanti, D H Van Thiel.   

Abstract

Hepatic transplantation for metabolic or genetic diseases of the liver produces a definite cure of the liver disease and also effectively cures the underlying metabolic abnormalities of the genetic disease in question. Liver transplantation is highly likely to become the current treatment of choice for a wide variety of metabolic disorders based predominantly in the liver. This is true not only for those that produce grossly evident hepatic disease with cirrhosis, but also for those that are free of obvious hepatocellular injury but are based either predominantly or exclusively within the liver.

Entities:  

Mesh:

Year:  1988        PMID: 3292426

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

Review 1.  [Acute Wilson disease].

Authors:  D Huster; W Hermann; M Bartels
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

Review 2.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

3.  Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Authors:  K Paradis; A Weber; E G Seidman; J Larochelle; L Garel; C Lenaerts; C C Roy
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

4.  Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma.

Authors:  C O Esquivel; L Mieles; I R Marino; S Todo; L Makowka; G Ambrosino; P Nakazato; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

5.  Intractable neurological Wilson's disease treated with orthotopic liver transplantation.

Authors:  A L Mason; W Marsh; D H Alpers
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Role of plasmapheresis in the management of acute hepatic failure in children.

Authors:  A L Singer; K M Olthoff; H Kim; E Rand; G Zamir; A Shaked
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

7.  Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.

Authors:  Yoshitaka Wakizaka; Toshio Miki; Abdul S Rao; Xue Wang; April L Goller; Anthony J Demetris; John J Fung; Thomas E Starzl; Luis A Valdivia
Journal:  Xenotransplantation       Date:  1997-11-01       Impact factor: 3.907

8.  Liver transplantation. Initial experience in the Veterans Administration.

Authors:  R I Leventhal; D H Berman; S Lasky; J S Gavaler; V Dindzans; E Urban; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

9.  Liver transplantation for the treatment of urea cycle disorders.

Authors:  P F Whitington; E M Alonso; J T Boyle; J P Molleston; P Rosenthal; J C Emond; J M Millis
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

Review 10.  Treatment of inherited metabolic disorders by liver transplantation.

Authors:  M Burdelski; B Rodeck; A Latta; K Latta; J Brodehl; B Ringe; R Pichlmayr
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.